Simplex Trading
FRTX

Simplex Trading’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Simplex Trading’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Hold
0
– -$1K – 7999
2019
Q1 		– Hold
0
– – – 6964
2018
Q3 		– Hold
0
– -$7K – 8253
2018
Q2 		– Hold
0
– – – 6567
2016
Q1 		– Hold
0
– -$1K – 6427
2015
Q4 		– Hold
0
– – – 5058
2015
Q3 		– Hold
0
– – – 5208
2015
Q2 		– Hold
0
– – – 3907
2015
Q1 		– Hold
0
– – – 4666
2014
Q4 		– Hold
0
– – – 4351

Other funds holding FRTX

PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's FRTX Position: Q3 2019 in Review

Simplex Trading sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2019, closing a stake of 3 shares — an estimated $689 sold.

Simplex Trading first reported a position in FRTX in Q1 2015 and held it in 10 quarters. The position peaked at $6K in Q2 2016. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2019.

  • Simplex Trading reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Simplex Trading sold 3 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $689.
  • Simplex Trading first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2015 and held it in 10 quarters.
  • Simplex Trading's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $6K in Q2 2016.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.